-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
A brief, oral history of mask blocs: Part 1
-
“Perfect storm” of criminalization: Analyzing mask bans
-
Q&A: NIH Director Dr. Monica Bertagnolli on next steps for RECOVER, future Long Covid research plans, and more
-
Sen. Bernie Sanders introduces $10 billion Long Covid Moonshot legislation to support research, healthcare, education
-
New NASEM reports offer broad definition, highlight the seriousness of Long Covid
-
Black and Unbelieved: A conversation with filmmaker Chimére Sweeney
Science
-
Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?
-
Research updates, October 28
-
Research updates, October 21
-
Nicotine patches help relieve symptoms in some people with Long COVID. Can the science behind it lead to future therapies?
-
Research updates, October 14
-
Getting diagnosed with hypermobility can help some people with Long COVID. Upcoming guidelines may make it easier.
Covid-19
Health
-
Breaking: Vital Long COVID data taken down following Trump order
-
The “pandemic of abandonment”: Navigating friendships five years into COVID-19
-
As someone with Long COVID, I’m terrified of what could happen to the Affordable Care Act
-
Long COVID is a smoldering threat to wildland firefighters
-
COVID-19 advocates are distributing masks to protect Californians from wildfire smoke
-
How America lost control of the bird flu, setting the stage for another pandemic
